Ascendis Pharma A/S (Ascendis Pharma A/S) Pre-Tax Income : $-510.3 Mil (TTM As of Dec. 2023)

Ascendis Pharma A/S Pre-Tax Income Chart

Ascendis Pharma A/S Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Pre-Tax Income		Get a 7-Day Free Trial					-242.50	-509.94	-433.84	-612.09	-517.06

Ascendis Pharma A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Pre-Tax Income	Get a 7-Day Free Trial															-214.06	-117.36	-132.03	-172.44	-88.43

Competitive Comparison of Ascendis Pharma A/S's Pre-Tax Income

For the Biotechnology subindustry, Ascendis Pharma A/S's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascendis Pharma A/S's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascendis Pharma A/S's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Ascendis Pharma A/S's Pre-Tax Income falls into.

Ascendis Pharma A/S Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Ascendis Pharma A/S's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Ascendis Pharma A/S's Pretax Income for the quarter that ended in Dec. 2023 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-510.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Pharma A/S  (NAS:ASND) Pre-Tax Income Explanation

Ascendis Pharma A/S's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

During the past 13 years, Ascendis Pharma A/S's highest Pretax Margin was -73.95%. The lowest was -8127.44%. And the median was -1362.67%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascendis Pharma A/S Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma A/S's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma A/S (Ascendis Pharma A/S) Business Description